LexDanaLexDanabeta
Inventor

QIAOYU XU

Inventor
CN

Overview

2→
Patents
2024–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
12,514,821Pharmaceutical TACI-Fc fusion protein formulation202612,171,840Anti-mesothelin antibody and antibody drug conjugate thereof2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024Patents assigned to REMEGEN LTD (1)· patent assignee history
2024–2026Based in CN· patent location history
2026Patents assigned to REMEGEN CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
REMEGEN CO LTD12026
REMEGEN LTD12024
Locations
LocationPatentsSpan
CN22024–2026